Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients
试验速览
- 阶段
- 不适用
- 入组人数
- 96
- 主要终点
- measure plasma level of interleukin 38 in all groups
研究概览
简要总结
case control study to compare level of interleukin 38 in patients with psoriasis and patients with metabolic syndrome with healthy control subjects
详细描述
this case control study will measure plasma level of interleukin 38 in 4 groups of 24 subject, group one will have psoriatic patients, group 2 will have psoriatic patients with metabolic syndrome, group three will have patients with metabolic syndrome only, and group 4 will have healthy control subjects.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •specific to each group
排除标准
- •Patient refusal. Age <18 years Pregnancy Lactation smoking Infections. Patients with other inflammatory skin disorders use of antioxidant and anti-inflammatory drugs patients on treatment for psoriasis
结局指标
主要结局
measure plasma level of interleukin 38 in all groups
时间窗: through study completion an average of 18 months
level of interleukin 38 will be measured and compared in all groups to asses the relationship between this interleukin and metabolic syndrome in psoriatic patients
次要结局
未报告次要终点
研究者
Yomna Abdo Abdellatif
resident doctor in dermatology venereology and andrology department in sohag university hospital
Sohag University